Clinical Trials Browser

Recruiting × Recurrence × Receptors, Chimeric Antigen × Clear all

NCT05852717 2026-01-12

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Phase 2 Recruiting

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse